IrelandCampaigners Urge HSE to Approve Friedreich’s Ataxia Drug Skyclarys in Ireland
Campaigners are calling on the Health Service Executive (HSE) in Ireland to approve reimbursement for Skyclarys, a drug that slows the progression of Friedreich’s Ataxia, a rare neuromuscular condition.
Quorum · collective opinions
Campaigners Urge HSE to Approve Friedreich’s Ataxia Drug Skyclarys
First report 19h agoLast update 19h ago1 takes▲ 1
advocacy approve drugpositiveShow 1 post
started 19h ago•Last update 19h ago
Campaigners are actively advocating for the HSE to approve and reimburse the drug Skyclarys for patients with Friedreich’s Ataxia.
iWitness comments
No comments yet — be the first to weigh in.